Remission of a Refractory, Anaplastic Large-Cell Lymphoma after Treatment with Daclizumab
O. Lindén
- 30 Sep, 2004
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
